Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Long-Term Outcome Of Acute Promyelocytic Leukemia (APL) With Lower Initial Leukocyte Counts By Using All- Trans Retinoic Acid (ATRA) Alone For Remission Induction Therapy: Japan Adult Leukemia Study Group (JALSG) APL97 Study

Takaaki Ono, MD, PhD, Akihiro Takeshita, MD, PhD, Katsuji Shinagawa, MD, PhD, Yuji Kishimoto, MD, PhD, Hitoshi Kiyoi, MD, PhD, Masaya Okada, MD, PhD, Takahiro Yamauchi, MD, PhD, Nobuhiko Emi, MD, PhD, Hiroyuki Fujita, MD, Mitsuhiro Matsuda, MD, PhD, Fumihiko Monma, MD, PhD, Shigeki Ohtake, MD, PhD, Chiaki Nakaseko, M.D., Ph.D., Masatomo Takahashi, MD, PhD, Yukihiko Kimura, MD, PhD, Masako Iwanaga, MD, PhD, MPH, Norio Asou, MD, PhD, Tomoki Naoe, MD, PhD

Blood (2013) 122 (21): 3950.

https://doi.org/10.1182/blood.V122.21.3950.3950

Published: 2013

Journal Articles

Clinical Features and Prognostic Impact of CD56 Expression in Acute Promyelocytic Leukemia: Long Term Follow up Data From the Japan Adult Leukemia Study Group(JALSG) APL97,

Blood (2011) 118 (21): 3608.

https://doi.org/10.1182/blood.V118.21.3608.3608

Published: 2011

Journal Articles

Clinical Features and Outcomes of Elderly Patients with Acute Promyelocytic Leukemia (APL) - the Japan Adult Leukemia Study Group APL97 Study.

Blood (2010) 116 (21): 1077.

https://doi.org/10.1182/blood.V116.21.1077.1077

Published: 2010

Journal Articles

Outcome by Treatment Including An Intensified Consolidation Program with Dose-Escalated Doxorubicin for Newly Diagnosed Acute Lymphoblastic Leukemia (ALL): A Study by the Japan Adult Leukemia Study Group (JALSG ALL97 study).

Itsuro Jinnai, MD, Tohru Sakura, MD, Motohiro Tsuzuki, MD, Yasuhiro Maeda, MD, PhD, Noriko Usui, MD, Masayuki Kato, MD, Hirokazu Okumura, MD, PhD, Yasunori Ueda, MD, Yuji Kishimoto, MD, Fumiharu Yagasaki, MD, Jin Takeuchi, MD, Masako Iwanaga, MD, Yasushi Miyazaki, MD, Shuichi Miyawaki, MD, Kazunori Ohnishi, MD, PhD, Tomoki Naoe, MD, Ph.D., Ryuzo Ohno, MD

Blood (2009) 114 (22): 4334.

https://doi.org/10.1182/blood.V114.22.4334.4334

Published: 2009

Journal Articles

A Phase 2 Open-Label, Sequential-Cohort, Dose-Escalation Study of AMG 531 in Japanese Patients with Chronic Immune Thrombocytopenic Purpura (ITP).

Yukari Shirasugi, Kiyoshi Ando, Satoshi Hashino, Toshiro Nagasawa, Yoshiyuki Kurata, Yuji Kishimoto, Koji Iwato, Yusuke Sonehara, Masayuki Ohkura, Tomoko Ohtsu, Janet L. Nichol

Blood (2007) 110 (11): 1308.

https://doi.org/10.1182/blood.V110.11.1308.1308

Published: 2007

Journal Articles

A randomized study with or without intensified maintenance chemotherapy in patients with acute promyelocytic leukemia who have become negative for PML-RARα transcript after consolidation therapy: The Japan Adult Leukemia Study Group (JALSG) APL97 study

Blood (2007) 110 (1): 59–66.

https://doi.org/10.1182/blood-2006-08-043992

Published: 2007

Includes: Supplemental data

Journal Articles

A Randomized Study with or without Intensified Maintenance Chemotherapy in Patients with Acute Promyelocytic Leukemia Who Had Become Negative for PML-RARα Transcript after Consolidation Therapy: The Japan Adult Leukemia Study Group (JALSG) APL97 Study.

Norio Asou, MD, Yuji Kishimoto, MD, Hitoshi Kiyoi, MD, Masaya Okada, MD, Yasukazu Kawai, MD, Motohiro Tsuzuki, MD, Kentaro Horikawa, MD, Mitsuhiro Matsuda, MD, Katsuji Shinagawa, MD, Tohru Kobayashi, MD, Shigeki Ohtake, MD, Miki Nishimura, MD, Masatomo Takahashi, MD, Fumiharu Yagasaki, MD, Akihiro Takeshita, MD, Yukihiko Kimura, MD, Masako Iwanaga, MD, Tomoki Naoe, MD, Ryuzo Ohno, MD

Blood (2006) 108 (11): 2009.

https://doi.org/10.1182/blood.V108.11.2009.2009

Published: 2006

Journal Articles

Prognosis of Acute Myeloid Leukemia with Translocation (8;21): A Survey of 142 Cases Investigated in the JALSG AML97 Study.

Nahoko Hatsumi, Shuichi Miyawaki, MD, PhD, Hisashi Sakamaki, MD, Shigeki Ohtake, MD, Fumiharu Yagaski, MD, Kinuko Mitani, MD, Shin Matsuda, MD, Yuji Kishimoto, MD, Yasushi Miyazaki, MD, Norio Asou, MD, Sumihisa Honda, MD, Masafumi Taniwaki, MD, Ryuzo Ohno, MD

Blood (2005) 106 (11): 4511.

https://doi.org/10.1182/blood.V106.11.4511.4511

Published: 2005

Journal Articles

Role of IL-4-Producing CD8+ T Cells in Patients with Chronic Graft-Versus-Host Disease (cGVHD) and in Normal Healthy Volunteer.

Kengo Nakamura, Masashi Takebayashi, Kenichirou Tajima, Tsutomu Tanijiri, Takashi Yokoi, Yonsu Son, Noriaki Matsumoto, Katsuhiro Zen, Yuji Kishimoto, Ryuichi Amakawa, Shirou Fukuhara

Blood (2004) 104 (11): 4970.

https://doi.org/10.1182/blood.V104.11.4970.4970

Published: 2004

Journal Articles

Postremission Therapy in Adult Acute Myeloid Leukemia (AML): A Randomized Comparison of Intensified Consolidation Therapy without Maintenance Therapy Against Conventional Consolidation with Maintenance Therapy -JALSG AML-97 Trial-.

Shuichi Miyawaki, M.D., Hisashi Sakamaki, M.D., Shigeki Ohtake, M.D., Fumiharu Yagasaki, M.D., Kinuko Mitani, M.D., Shin Matsuda, M.D., Yuji Kishimoto, M.D., Yasushi Miyazaki, M.D., Norio Asou, M.D., Yoshiaki Ogawa, M.D., Sumihisa Honda, M.D., Ryuzo Ohno, M.D.

Blood (2004) 104 (11): 868.

https://doi.org/10.1182/blood.V104.11.868.868

Published: 2004

Journal Articles

Postremission Treatment with Chemotherapy or Allogeneic Stem Cell Transplantation (Allo-SCT) in Adults with Acute Myeloid Leukemia (AML) -JALSG AML-97 Trial-.

Hisashi Sakamaki, M.D., Shuichi Miyawaki, M.D., Shigeki Ohtake, M.D., Fumiharu Yagasaki, M.D., Kinuko Mitani, M.D., Shin Matsuda, M.D., Yuji Kishimoto, M.D., Yasushi Miyazaki, M.D., Norio Asou, M.D., Yoshiaki Ogawa, M.D., Sumihisa Honda, Ph.D., Ryuzo Ohno, M.D.

Blood (2004) 104 (11): 2298.

https://doi.org/10.1182/blood.V104.11.2298.2298

Published: 2004

NARROW

Long-Term Outcome Of Acute Promyelocytic Leukemia (APL) With Lower Initial Leukocyte Counts By Using All- Trans Retinoic Acid (ATRA) Alone For Remission Induction Therapy: Japan Adult Leukemia Study Group (JALSG) APL97 Study

Clinical Features and Prognostic Impact of CD56 Expression in Acute Promyelocytic Leukemia: Long Term Follow up Data From the Japan Adult Leukemia Study Group(JALSG) APL97,

Clinical Features and Outcomes of Elderly Patients with Acute Promyelocytic Leukemia (APL) - the Japan Adult Leukemia Study Group APL97 Study.

Outcome by Treatment Including An Intensified Consolidation Program with Dose-Escalated Doxorubicin for Newly Diagnosed Acute Lymphoblastic Leukemia (ALL): A Study by the Japan Adult Leukemia Study Group (JALSG ALL97 study).

A Phase 2 Open-Label, Sequential-Cohort, Dose-Escalation Study of AMG 531 in Japanese Patients with Chronic Immune Thrombocytopenic Purpura (ITP).

A randomized study with or without intensified maintenance chemotherapy in patients with acute promyelocytic leukemia who have become negative for PML-RARα transcript after consolidation therapy: The Japan Adult Leukemia Study Group (JALSG) APL97 study

A Randomized Study with or without Intensified Maintenance Chemotherapy in Patients with Acute Promyelocytic Leukemia Who Had Become Negative for PML-RARα Transcript after Consolidation Therapy: The Japan Adult Leukemia Study Group (JALSG) APL97 Study.

Prognosis of Acute Myeloid Leukemia with Translocation (8;21): A Survey of 142 Cases Investigated in the JALSG AML97 Study.

Role of IL-4-Producing CD8+ T Cells in Patients with Chronic Graft-Versus-Host Disease (cGVHD) and in Normal Healthy Volunteer.

Postremission Therapy in Adult Acute Myeloid Leukemia (AML): A Randomized Comparison of Intensified Consolidation Therapy without Maintenance Therapy Against Conventional Consolidation with Maintenance Therapy -JALSG AML-97 Trial-.

Postremission Treatment with Chemotherapy or Allogeneic Stem Cell Transplantation (Allo-SCT) in Adults with Acute Myeloid Leukemia (AML) -JALSG AML-97 Trial-.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only